Submit an Article
Navigate
Home
Editorial Board
Editorial Policies
Current Volume
Archive
Scientific Integrity
Publication Ethics Statements
Interviews with Outstanding Authors
Newsroom
Sponsored Conferences
Podcast
Contact
Special Collections
Submit an Article
Online ISSN: 1945-4589
Research Paper
|
Volume 14, Issue 12
|
pp. 5211–5222
DNA methylation-regulated SNX20 overexpression correlates with poor prognosis, immune cell infiltration, and low-grade glioma progression
Back to article
Figure 1
(1 of 10)
−
100%
+
Figure 1.
SNX20 is highly expressed in LGG.
(
A
) The expression of SNX20 in pan-cancer examined by TCGA database. (
B
–
D
) The expression of SNX20 in LGG examine by TCGA/GEO databases.